Press Releases January 29, 2024

Perkins&Will Expands cGMP Expertise in Boston

The strategic growth of the process architecture and cGMP design team strengthens firmwide expertise in clean room facility planning and design.

BOSTONPaul Szafir, a leading architect in the cGMP design field, joins the Boston studio of Perkins&Will as associate director of process architecture and cGMP design. Szafir’s arrival ushers in a period of exciting, continued growth of cGMP services within the firm’s Science and Technology practice. With over fifteen years of experience spanning architecture and engineering, Szafir specializes in biopharmaceutical cGMP facility design for clinical research and commercial manufacturing. He has helped deliver projects both locally and nationally for notable pharmaceutical companies including Biogen, CRISPR Therapeutics, Pfizer, and ThermoFisher.

cGMP facilities lie at the intersection of novel science, innovative design, and complex engineering,” states Dr. Jim Levin, the director of process architecture and cGMP design in Perkins&Will’s Boston studio. With Paul on the team, I am excited to leverage our shared expertise to deliver efficient and high-quality facilities that produce life-saving therapies.” 


A Powerful Partnership 

Szafir joins Levin in co-leading the cGMP practice, strengthening the firm’s capabilities to deliver holistic planning and design services. Together, Levin and Szafir will blend their specialized expertise to solve complex problems and realize high project aspirations. As a Board-certified veterinarian, former Senior VP of a pharmaceutical company, and a veteran lab manager, Levin brings a uniquely user-centric perspective to designing clean room and manufacturing spaces. Working most recently within an engineering-focused firm, Szafir’s expertise in capacity, compliance, and regulatory requirements will elevate the delivery of technically focused solutions.

cGMP Clean room
Clean room and manufacturing facilities enable the discovery and production of life-saving medicines.

Local Presence, National Reach 

With cGMP leadership based in Boston, Perkins&Will continues a strong presence in Kendall Square, colloquially referred to as ”the most innovative square mile on the planet,” contributing to the Cambridge district’s growth as a hub of scientific discovery. This localized cGMP expertise serves a national client base, with project work spanning across academic centers, healthcare providers, government institutions, and commercial developers. Recent significant projects include research, cell processing, and manufacturing facilities for Evolve Biologics, Sana Biotechnology, Just Evotec Biologics, and the National Institute of Health (NIH).  

The science and technology marketplace is rapidly evolving and the advancement of processes to treat diseases is increasing the need for specialized cGMP spaces,” states Jeffrey R. Zynda, regional science and technology practice leader at Perkins&Will. We are continuing to enhance our design approach to meet these needs, always focusing on improving environments for discovery and development.” 


Delivering High-Quality Design  

Perkins&Will‘s design approach is tailored to best serve the people that work in clean room and manufacturing facilities and the products that come out of them. By focusing on people, process, and quality, the firm is poised to create high-value spaces as the industry shifts towards increasing speed-to-market and speculative lab demands. Through early client engagement, the cGMP team ensures regulatory and process needs are met, while exploring design synergies that can enhance the user-experience. From initial core and shell projects to final tenant space design, the team serves as trusted advisors across the lifecycle of cGMP facilities, providing time-saving, cost-saving, and people-focused solutions.